510(k) Report

FDA product code · Hematology

Analyzer, Heparin, Automated

JOXClass II21 CFR 864.5680510(k) required15 decisions since 19802 recalls

15 FDA decisions since 1980. 2 recalls name this code, 0 of them Class I. The most-cited predicate is K894317, named by 5 later devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, hematology panel

Twenty years of JOX at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · JOX

1in 2011

2010: 22011: 1
2007high 2 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JOX

Too few JOX 510(k)s in any year since 2007 to give a median.

Recalls per year · JOX

1in 2009

2009: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JOX

65in 2025

2014: 32019: 12022: 292023: 502024: 302025: 65
2007high 65 (2025) · low 0 (2007)2025

MAUDE reports naming product code JOX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—10
20102—00
20111—00
20120—00
20130—00
20140—03
20150—00
20160—00
20170—00
20180—00
20190—01
20200—00
20210—00
20220—029
20230—050
20240—030
20250—065
20260—0—
FIG. 1 — JOX by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in JOX? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report